TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 171 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,915 | -37.5% | 19,118 | +7.4% | 0.00% | -50.0% |
| Q2 2023 | $273,362 | -23.1% | 17,797 | +12.6% | 0.00% | -33.3% |
| Q1 2023 | $355,454 | +10.2% | 15,805 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $322,600 | -10.6% | 15,340 | +4.6% | 0.00% | -25.0% |
| Q3 2022 | $361,000 | +2.3% | 14,671 | +0.8% | 0.00% | +33.3% |
| Q2 2022 | $353,000 | -8.1% | 14,561 | -2.2% | 0.00% | 0.0% |
| Q1 2022 | $384,000 | -16.0% | 14,895 | +1.3% | 0.00% | 0.0% |
| Q4 2021 | $457,000 | +27.3% | 14,708 | -0.8% | 0.00% | 0.0% |
| Q3 2021 | $359,000 | +74.3% | 14,821 | +5.2% | 0.00% | +50.0% |
| Q2 2021 | $206,000 | -45.4% | 14,092 | -6.6% | 0.00% | -33.3% |
| Q1 2021 | $377,000 | +10.2% | 15,091 | +20.3% | 0.00% | 0.0% |
| Q4 2020 | $342,000 | – | 12,548 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |